noom microdosing glp 1 Small just got more powerful: Noom's most advanced program is now available in a low dose. Microdose GLP-1Rx Plus combines personalized, Compounded Tirzepatide GLP-1 treatment prescribed by licensed clinicians with healthy habits Proactive health starts here |

Tirzepatide (a dual GIP/GLP-1 medication, injected weekly) has produced higher average weight loss in trials, often near or above 20% depending on the dose and study

However, evidence remains insufficient

What to Expect in Months 7-11 Essentially no side effects: Appetite suppression continues (desired effect), but GI symptoms gone Weight loss velocity slows: From 0.8kg/week (months 3-6) to 0.3-0.5kg/week Plateau around week 40-48: Weight stabilizes, no longer losing despite continued medication Total weight loss: Average 20-24% from baseline (matching or exceeding surgical outcomes) Focus shifts to maintenance: Accepting current weight, preventing regain Plateau frustration: Not a side effect but an emotional challenge 2 Final Strategies for Months 7-11 20

Tyrosinase inhibition

All models exhibited increased lung inflammation and emphysema due to PM exposure